Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/23836
Title: Oxygen for interstitial lung diseases.
Authors: Khor, Yet H;Smith, David J F;Johannson, Kerri A;Renzoni, Elisabetta
Affiliation: Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia
Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
Departments of Medicine & Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK
National Heart and Lung Institute, Imperial College, London, UK
Faculty of Medicine, University of Melbourne
Issue Date: 9-Jul-2020
EDate: 2020-07-09
Citation: Current opinion in pulmonary medicine 2020; online first 9 July
Abstract: Supplemental oxygen therapy is prescribed for management of hypoxaemia in patients with interstitial lung disease (ILD). This review summarizes current evidence and implications of the use of supplemental oxygen therapy at home and during exercise training in ILD. Despite the significance of hypoxaemia in patients with ILD, there is a lack of high-quality evidence to guide the use of oxygen therapy in this population. Recent studies suggest that ambulatory oxygen may improve symptoms and health-related quality of life in patients with ILD. Long-term oxygen therapy for resting hypoxaemia in ILD is recommended by international guidelines. Supplemental oxygen during exercise may augment training effects, whereas therapeutic effects of nocturnal oxygen therapy are yet to be evaluated in patients with ILD. Nevertheless, it is important to consider the potential burden imposed by oxygen therapy on patients' daily activities of living. Ambulatory oxygen may be considered in ILD patients with exertional hypoxaemia, with long-term oxygen therapy being a standard care for resting hypoxaemia. Trials are currently underway to clarify therapeutic potentials of supplemental oxygen for exertional hypoxaemia and during exercise training in ILD patients, with additional research needed for the evaluation of nocturnal oxygen therapy.
URI: http://ahro.austin.org.au/austinjspui/handle/1/23836
DOI: 10.1097/MCP.0000000000000691
ORCID: 0000-0002-5434-9342
PubMed URL: 32657832
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.